Heart transplant survival outcomes for adriamycin-dilated cardiomyopathy
AJ Lenneman, L Wang, M Wigger, H Frangoul… - The American journal of …, 2013 - Elsevier
In 2015, there will be an estimated 11.3 million cancer survivors. With an increasing
population of cancer survivors, it is imperative to understand the treatment options available
and outcomes for chemotherapy-related cardiomyopathy. Anthracycline-based
chemotherapy causes heart failure in approximately 5% of patients. Orthotopic heart
transplantation (OHT) is an option for cancer survivors in complete remission who develop
end-stage heart failure. We examined retrospective OHT data collected from the United …
population of cancer survivors, it is imperative to understand the treatment options available
and outcomes for chemotherapy-related cardiomyopathy. Anthracycline-based
chemotherapy causes heart failure in approximately 5% of patients. Orthotopic heart
transplantation (OHT) is an option for cancer survivors in complete remission who develop
end-stage heart failure. We examined retrospective OHT data collected from the United …
以上显示的是最相近的搜索结果。 查看全部搜索结果